Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 291 trials across Europe, recruiting first
Study on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
BelgiumLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
AustriaStudy of Pembrolizumab and Lenvatinib for Patients with Malignant Pleural Mesothelioma in Second and Third Line Treatment
The NetherlandsStudy on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal
GermanyStudy on Ceralasertib, Oleclumab, and Monalizumab for Advanced Non-Small Cell Lung Cancer Patients Resistant to PD-1 Inhibitors
FranceStudy Comparing Cemiplimab to Platinum-Based Chemotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
BulgariaStudy of Cemiplimab and Chemotherapy Combination for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19
BelgiumStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
AustriaStudy of Lurbinectedin and Atezolizumab in Patients with Advanced Small Cell Lung Cancer Who Have Previously Received Platinum Chemotherapy
SpainStudy on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer
The NetherlandsStudy on Amivantamab, Lazertinib, and Bevacizumab for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer After Treatment Progression
FranceThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
